Scopolamine Market - Top Companies and Manufacturers

Companies Dominating the Scopolamine Landscape

Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Baxter International Inc.
Myungmoon Pharm Co. Ltd
Alchem International Pvt. Ltd.
Caleb Pharmaceuticals, Inc.
GlaxoSmithKline plc
Aktivax, Inc.
Southwest Research Institute
Perrigo Company plc
Novartis International AG

Browse Key Market Insights with Data Illustration:

Scopolamine Market Size & Share - Growth Report 2037

In the News

Southwest Research Institute developed a fully synthetic method to produce scopolamine which is a plant-based medicine. This was developed to improve the drug availability which was disrupted by wildfires, climatic conditions, pests, crop diseases, and weather.
Aktivax, Inc. was awarded a USD 24.5 million US government project for developing a scopolamine autoinjector under a 5-year OT agreement with the approval of the U.S. Food and Drug Administration. The autoinjector was developed to treat the poisoning of organophosphate nerve agents in the military.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of scopolamine is assessed at USD 556.1 billion.

The scopolamine market size was valued at USD 511.78 billion in 2024 and is expected to reach USD 1001.5 billion by 2037, expanding at around 5.3% CAGR during the forecast period i.e., between 2025-2037. Increasing number of surgical procedures, the number of people suffering from digestive disorders, and psychological disorders will boost the market growth.

Asia Pacific industry is estimated to dominate majority revenue share of 32% by 2037, attributed to increasing number of people suffering from ophthalmic disorders and the increasing number of surgeries in the elderly population.

The major players in the market are Pfizer Inc., Baxter International Inc., Myungmoon Pharm Co. Ltd, Alchem International Pvt. Ltd., Caleb Pharmaceuticals, Inc., GlaxoSmithKline plc, Aktivax, Inc., Southwest Research Institute, Perrigo Company plc, Novartis International AG

Scopolamine Market - Top Companies and Manufacturers

Companies Dominating the Scopolamine Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the scopolamine market worth?

Why is the demand for scopolamine growing?

Which region dominated the majority of scopolamine industry share?

Who are the top scopolamine companies?